Rigicon Inc., with its global headquarters in NY, USA, announces that their innovative prosthetic urology portfolio received marketing approval from Australia (Australian Government Department of ...
RONKONKOMA, N.Y., Dec. 16, 2019 /PRNewswire-PRWeb/ -- Rigicon,Inc. announces that the U.S. Food and Drug Administration (FDA) has cleared Rigi10™ New Generation Malleable Penile Prosthesis for ...
The study included 535 patients who underwent Infla10® implantation between June 2019 and April 2022, with 103 surgeons from 26 centers participating. Patients were followed up to evaluate the safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback